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The pyruvate and a-ketoglutarate dehydrogenase complexes isolated from pig heart mitochondria promote the reduction of thioredoxin in the 
presence of their a-ketoacid substrates, coenzyme A, and free lipoate. Substrate-specific generation of reduced thioredoxin was established by two 
independent methods, viz. reduction of insulin and thioredoxin reductase-catalyzed NADPH formation. Dihydrolipoate accumulating in the 
absence of NAD’ is the likely intermediate. A redox function in a-ketoacid oxidation provides a potential role for the specific thioredoxins 
previously identified by us in mitochondria. 
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1. INTRODUCTION 
Thioredoxins are small proteins containing a redox- 
active di-cysteine structure. They are involved in a vari- 
ety of physiologically important functions by virtue of 
their ability to serve as hydrogen donors or to reduce 
disulfide bonds in proteins [l]. Oxidized thioredoxins 
can be reduced at the expense of NADPH in the reac- 
tion catalyzed by thioredoxin reductase [I]. However, 
they are easily reduced also by dithiols, including dihy- 
drolipoate [2]. The latter is known to be an intermediate 
in the oxidative decarboxylation of a-ketoacids cata- 
lyzed by the a-ketoacid dehydrogenase complexes 
(equations l-3) [3]. 
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In reaction (l), the reducing equivalents from an a- 
ketoacid oxidized by the dehydrogenase complex com- 
ponent El are accepted by lipoic acid covalently bound 
to the second enzyme, dihydrolipoate acyltransferase 
(E2). Dihydrolipoate is generated after acyl transfer 
from acyldihydrolipoate to coenzyme A (reaction 2). In 
*Corresponding author. 
Abbreviations: CoA, coenzyme A; lip, lipoate; KGD, a-ketoglutarate 
dehydrogenase. 
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the presence of NAD’ dihydrolipoate is reoxidized by 
dihydrolipoate dehydrogenase E3 (reaction (3)) In the 
absence of NAD’, however, the EZbound dihydro- 
lipoate can be oxidized by other means. We suggested 
that its reducing equivalents are transferred to the ex- 
cess of lipoic acid present in solution, either through 
non-enzymatic thiol-disulfide exchange reactions be- 
tween enzyme-bound dihydrolipoate and free lipoate, 
or catalyzed by E3 which, after reduction by enzyme- 
bound dihydrolipoate, is capable of effectively reducing 
free lipoate. 
Thus, in the presence of lipoate instead of NAD’, 
a-ketoacid dehydrogenases may be expected to accumu- 
late dihydrolipoate during the oxidation of their a-ke- 
toacid substrates. As far as we know, there are no data 
in the literature about this reaction. Only El-dependent 
reductive acylation of free lipoate (i.e. reaction (1) with 
free lipoate), and the transacylation reaction between 
enzyme-bound acyldihydrolipoate and free lipoate have 
been studied [4]. However, these reactions proceeded 
only to a very limited extent. 
The aim of this work was to study the possibility and 
efficiency of thioredoxin reduction dependent on the 
dihydrolipoate formed during a-ketoglutarate or py- 
ruvate oxidation catalyzed by the a-ketoglutarate or 
pyruvate dehydrogenase complex, respectively. It has 
been prompted by our earlier observation of specific 
mitochondrial thioredoxins [5,6], which are in search of 
a function. 
2. MATERIALS AND METHODS 
The a-ketoglutarate and pyruvate dehydrogenase complexes were 
isolated from pig hearts in parallel according to [7], omitting final 
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chromatographic separation on Sepharose CL-2B. Triton X-100 was 
included only during extraction of the complexes from the tissue. The 
preparation from pig heart did not permit separation of the a-ketoglu- 
tarate and pyruvate dehydrogenase complexes by differential polyeth- 
ylene glycol precipitation as described for the enzymes from bovine 
heart [7]. The purified fraction containing both complexes was used 
for thioredoxin reduction. 
Thioredoxin reductase was obtained from E. coli cells according to 
[S]. Thioredoxin from E. coli (oxidized) was from Calbiochem; coen- 
zymes, insulin, o,L-lipoic acid and dithiothreitol were from Serva; 
a-ketoglutarate, pyruvate and cysteine from Merck. 
Kinetic measurements were done at room temperature in 0.1 M 
potassium phosphate buffer pH 7.0 with the specified components, 
using Kontron 930 or Aminco DW 2000 spectrophotometers. 
3. RESULTS 
Thioredoxin is known to catalyze the reduction of 
insulin by dithiols [2]. Precipitation of the free B-chains 
liberated by reduction results in an increase in the tur- 
bidity of the reaction mixture measurable at 650 nm. 
This spectrophotometric assay proved well suited to 
demonstrate the a-ketoacid-dependent reduction of 
thioredoxin. a-Ketoglutarate or pyruvate were oxidized 
by the corresponding enzyme complex in the presence 
of 0.248 mM CoA as the acyl residue acceptor and l-4 
mM lipoate as the possible electron acceptor. Only 
when thioredoxin was present in the reaction medium 
could insulin reduction be observed (Fig. 1, curves 1 and 
2). The reaction was dependent on the thioredoxin con- 
centration as well as on the amount of lipoate and of the 
10 min 
Fig. 1. Reduction of insulin, measured at 650 nm, by E. coli thiore- 
doxin coupled to u-ketoacid dehydrogenase complexes from pig heart 
mitochondria. Curve 1: a-Keto-glutarate dehydrogenase/a-ketogluta- 
rate; curve 2: pyruvate dehydrogenase/pyruvate; curve 3: 1 mM dithio- 
threitol, no enzyme (control). See Table I for concentrations, other 
components, and conditions. 
enzyme complex (Table I). It was also strictly dependent 
on the cc-ketoacid substrates, indicating that the thiol 
groups of coenzyme A and of cysteine (required for the 
reduced state of CoA) present in solution did not con- 
tribute to the observed rate of insulin reduction. 
Insulin reduction dependent on a-ketoacid oxidation 
plus thioredoxin was qualitatively comparable to that 
produced by 1 mM dithiothreitol (Fig. 1, curve (3)). 
Obviously, the rates of the enzyme-linked reactions 
were limited by the a-ketoacid dehydrogenase activities, 
Table I 
Maximum rates of a-ketoacid dehydrogenase- and thioredoxin-dependent i sulin reduction” 
Components of reaction mixture Thioredoxin 
(ug . ml-‘) 
Other variable component AA650 . min-’ 
Pyruvate dehydrogenaseb, substrate pyruvate (4 mM) 
Complex, 0.24 mg . ml-’ 
Thiamine-PP, 0.4 mM 
Coenzyme A, 0.8 mM 
Lipoate, 4 mM 
MgCI,, 1.2 mM 
a-Ketoglutarate dehydrogenaseb, substrate cc-ketoglutarate (2 mM) 
Complex, 0.08 mg ml-’ 
Coenzyme A, 0.4 mM 
Lipoate, 1.2 mM 
Complex 0.08 mg . ml-’ 
Lipoate, 1.2 mM 
Complex, 0.08 mg . ml-’ 
Coenzyme A, 0.8 mM 
Coenzyme A, 0.4 mM 160 complex, 0.02 mg . ml-’ 
Lipoate, 1.2 mM 160 0.08 
40 0.096 
80 0.188 
20 0.017 
40 0.048 
80 0.069 
160 0.094 
160 coenzyme A, 0.2 mM 0.055 
160 034 0.094 
160 0.8 0.099 
160 lipoate, 0.4 mM 
160 1.2 
160 4.0 
0.062 
0.110 
0.139 
0.035 
0.094 
a 0.9 mg insulin . ml-’ in potassium phosphate buffer, pH 7.0. 
bReferred to as complex. 
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in accord with the 1.7-fold lower pyruvate-NAD’ re- 
ductase activity in the enzyme fraction used and the 
dependence of insulin reduction on the complex con- 
centration (Table I). 
It must be noted that the half-maximal rate of the 
reaction studied was obtained at substrate concentra- 
tions (> 0.4 mM a-ketoglutarate and 0.2 mM CoA) 
higher than the known K, values of a-ketoglutarate 
(0.01-0.2 mM) and CoA (0.0001-0.0035 mM) deter- 
mined for the pig heart KGD complex by different au- 
thors [9]. This discrepancy is due to the non-applicabil- 
ity of standard kinetics to the insulin reduction assay. 
It is impossible to measure the initial rate of a-ketoglu- 
tarate dehydrogenase reaction in this system which 
functions only when a high degree of substrate conver- 
sion to the products is reached. The lower substrate 
concentrations will be depleted before significant prod- 
uct accumulates and, consequently, do not induce meas- 
urable insulin precipitation. 
In a second approach, a-ketoacid-dependent thiore- 
doxin reduction was proved more directly by coupling 
the system with thioredoxin reductase. Thioredoxin re- 
ductase activity is usually determined in the direction of 
NADPH oxidation concomitant with thioredoxin re- 
duction. The reverse reaction, thioredoxin oxidation 
was followed in our experiments which allowed to de- 
tect thioredoxin reduced in the course of a-ketoacid 
oxidation. When NADP’ with thioredoxin reductase 
were added to a preincubation medium containing oxi- 
dized thioredoxin and the KGD complex with CZ- 
ketoglutarate, CoA and lipoate, NADP+ reduction was 
observed (Fig. 2). No reaction occurred in the absence 
of thioredoxin, or after preincubation of thioredoxin in 
a reaction medium without cr-ketoglutarate. The initial 
burst in NADPH production in such a system was de- 
Fig. 2. NADPH production in a reaction mixture containing E. coli 
thioredoxin (73 pg ml-‘), KGD complex (65 pg . mg-I), &-ketogluta- 
rate (3.6 mM), coenzyme A (1.1 mM), cysteine (2 mM), and lipoate 
(1.8 mM). After a 1 h incubation period, thioredoxin reductase 
(76 pg . ml-‘) and NADP+ (1.6 mM) were added and NADP+ reduc- 
tion was recorded at 340 nm. Arrows: additional portions of KGD 
complex (equal to the first amount of enzyme) were added at the 
indicated times. 
I 
0. 10 min 
*%o *ho 
Fig. 3. NADPH production in reaction mixtures containing NADP’ 
thioredoxin reductase, thioredoxin, and the a-ketoglutarate dehydro- 
genase complex without a preincubation period. (a) Complete system 
containing KGD (60 ,ug . ml-‘), a-ketoglutarate (3.3 mM), coenzyme 
A (0.7 mM), cysteine (1.4 mM), lipoate (1.7 mM), NADP’ (1.7 mM), 
thioredoxin reductase (80 pug. ml-‘) plus thioredoxin (33 pug. ml-‘) 
(curve 1) or without thioredoxin (control, curve 2). (b) Difference 
spectroscopy measurements with a sample cuvette containing the com- 
plete system as above and a reference cuvette containing the same 
mixture without thioredoxin-thioredoxin reductase. The reaction was 
started by simultaneous addition of KGD to both cuvettes. Arrow: 
addition of a second, identical quantity of KGD complex. 
termined by the accumulation of reduced thioredoxin in 
the preincubation medium; the burst amplitude depen- 
ded on the preincubation time and the thioredoxin con- 
tent (data not shown). It was followed by a slower, 
linear phase of NADP’ reduction determined by the 
production of dihydrolipoate in the KGD reaction. The 
reaction rate in this stationary phase increased propor- 
tionally with increasing amounts of KGD complex in 
the sample (Fig. 2, arrows 2 and 3). After prolonged 
incubation (more than one hour) the initial amount of 
enzyme added did no longer contribute much to the 
reaction rate, most likely because of the known inactiva- 
tion of KGD complex during the reaction [lo]. 
To couple thioredoxin reductase and KGD-pro- 
moted dihydrolipoate formation, NADPH production 
was also initiated by addition of the KGD complex to 
the complete system containing a-ketoglutarate, CoA, 
lipoate, oxidized thioredoxin, thioredoxin reductase, 
and NADP’. Complex spectral changes at 340 run were 
observed in this variant (Fig. 3) which can in part be 
attributed to the KGD reaction alone (Fig. 3a, control 
curve without thioredoxin). The rate of dihydrolipoate- 
thioredoxin-dependent NADPH production was better 
defined in difference measurements using the KGD- 
thioredoxin systems combined in the sample and only 
the KGD system in a reference cuvette (Fig. 3b). These 
values, then, became comparable to those in the station- 
ary phase of the experiments including a preincubation 
period (Fig. 2). Again, as in the case of insulin reduc- 
tion, the reaction was dependent on the amount of 
KGD complex (Fig. 4) and far higher activities were 
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Fig. 4. Dependence of thioredoxin reductase activity (NADPH pro- 
duction), in the presence of E. coli thioredoxin, on the concentration 
of a-ketoglutarate dehydrogenase complex. Conditions and reaction 
medium as in Fig. 3b. 
induced by 1 mM dithiothreitol, confirming the limiting 
role of KGD-catalyzed reactions in thioredoxin reduc- 
tion. 
4. DISCUSSION 
The possibility of thioredoxin reduction dependent on 
a-ketoglutarate or pyruvate oxidation in the presence of 
coenzyme A and free lipoate has been explored in the 
present work. Effective reduction of oxidized thiore- 
doxin present in such a medium could be established by 
two independent methods, utilizing the nascent reduced 
thioredoxin for reduction of insulin, or as a substrate of 
NADP-thioredoxin reductase. Obviously, the observed 
reduction of thioredoxin is based on the generation of 
dihydrolipoate by the a-ketoacid dehydrogenase com- 
plexes catalyzing oxidative decarboxylation in the ab- 
sence of NAD+ with coenzyme A as acyl and excess free 
lipoate as electron acceptor. No other compound capa- 
ble of reducing the disulfide bridge in an oxidized 
thioredoxin but reduced lipoate has been present in 
these reaction media. 
There are two aspects of interest in this reaction. On 
the one hand, lipoic acid is a pharmacological agent 
with many biological effects [l 11. It was shown that in 
some cases the disulfide of lipoate exerts an effect oppo- 
site to the action of glutathione disulfide [12]. This 
should reflect a special way of lipoate reduction inde- 
pendent of other cellular disulfides. a-Ketoacid-depend- 
ent reduction could be such a way. The possibility of 
transfer of reducing equivalents from dihydrolipoate to 
thioredoxin must be kept in mind in studying the biolog- 
ical effects of lipoic acid because of the multiple bio- 
chemical functions of reduced thioredoxin. 
On the other hand, the reaction is of major interest 
in connection with the existence of specific mitochon- 
drial thioredoxins [5,6]. We suggest that a-ketoacid- 
dependent hioredoxin reduction is an integral part of 
the thioredoxin cycle in mitochondria. The use of E: coli 
thioredoxin, which is available in substrate quantities, 
in our present work is warranted in view of the unspeci- 
ficity of the bacterial protein in vitro and its similarity 
to the mitochondrial, but not the cytoplasmic mammal- 
ian thioredoxin. More physiological conclusions, how- 
ever, will have to await experiments combining mito- 
chondrial thioredoxins and enzyme complexes from the 
same source. 
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